Literature DB >> 32531805

Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria.

J Castagna1, L Bernard2,3, F Hacard1,3, F Delcroix1,3, A-S Darrigade4, J-F Nicolas1,3, E Decullier2,3, A Nosbaum1,3, F Bérard1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32531805     DOI： 10.1111/bjd.19312

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

Review 1.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667

2.  Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study.

Authors:  Misbah Noshela Ghazanfar; Ewa Anna Bartko; Nicolai Skovbjerg Arildsen; Lars K Poulsen; Bettina Margrethe Jensen; Christian Enevold; Jesper Grønlund Holm; Anders Woetmann; Niels Ødum; Simon Francis Thomsen
Journal:  Clin Exp Allergy       Date:  2022-03-22       Impact factor: 5.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.